The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy

The second consensus criteria for the diagnosis of multiple system atrophy (MSA) are widely recognized as the reference standard for clinical research, but lack sensitivity to diagnose the disease at early stages.

[1]  W. Poewe,et al.  Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis , 2017, PloS one.

[2]  Raj Nair,et al.  Methods of formal consensus in classification/diagnostic criteria and guideline development. , 2011, Seminars in arthritis and rheumatism.

[3]  M. Schulzer,et al.  Early Clinical Features Differentiate Cerebellar Variant MSA and Sporadic Ataxia , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[4]  K. Miszkiel,et al.  “Hot cross bun” sign in a patient with parkinsonism secondary to presumed vasculitis , 2001, Journal of neurology, neurosurgery, and psychiatry.

[5]  Tove Faber Frandsen,et al.  The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review , 2018, Journal of the Medical Library Association : JMLA.

[6]  B. Boeve,et al.  Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies. , 2020, Annals of neurology.

[7]  N. Quinn,et al.  A validation exercise on the new consensus criteria for multiple system atrophy , 2009, Movement disorders : official journal of the Movement Disorder Society.

[8]  I Litvan,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.

[9]  W. Poewe,et al.  Automated Analysis of Diffusion‐Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease , 2020, Movement disorders : official journal of the Movement Disorder Society.

[10]  E. Tolosa,et al.  REM sleep behavior disorder and vocal cord paralysis in Machado‐Joseph disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[11]  R. Sakakibara,et al.  Bladder dysfunction as the initial presentation of multiple system atrophy: a prospective cohort study , 2018, Clinical Autonomic Research.

[12]  G K Wenning,et al.  Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism. , 2017, Parkinsonism & related disorders.

[13]  M. Yoshita,et al.  Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy , 1998, Journal of the Neurological Sciences.

[14]  S. Lorenzl,et al.  Which ante mortem clinical features predict progressive supranuclear palsy pathology? , 2017, Movement disorders : official journal of the Movement Disorder Society.

[15]  N. Quinn,et al.  “Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide , 2013, Movement disorders : official journal of the Movement Disorder Society.

[16]  N. Quinn,et al.  Multiple system atrophy--the nature of the beast. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[17]  P. Cortelli,et al.  The natural history of idiopathic autonomic failure , 2018, Neurology.

[18]  C. Soto,et al.  Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure , 2021, Annals of neurology.

[19]  M. T. Pellecchia,et al.  Stridor in multiple system atrophy , 2019, Neurology.

[20]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[21]  R. Freeman,et al.  Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness , 2021, Clinical Autonomic Research.

[22]  G. Chiro,et al.  Computed tomography, magnetic resonance imaging and positron emission tomography with [18F] fluorodeoxyglucose in multiple system atrophy and pure autonomic failure , 1991, Clinical Autonomic Research.

[23]  M. T. Pellecchia,et al.  Can Autonomic Testing and Imaging Contribute to the Early Diagnosis of Multiple System Atrophy? A Systematic Review and Recommendations by the Movement Disorder Society Multiple System Atrophy Study Group , 2020, Movement disorders clinical practice.

[24]  K. Ito,et al.  A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. , 1995, Journal of the autonomic nervous system.

[25]  Seung-June Oh,et al.  Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson's disease. , 2015, Parkinsonism & related disorders.

[26]  N. Quinn,et al.  Multiple system atrophy: A review of 203 pathologically proven cases , 1997, Movement disorders : official journal of the Movement Disorder Society.

[27]  Irene Litvan,et al.  Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study , 1999, Journal of neurology, neurosurgery, and psychiatry.

[28]  C. Adler,et al.  Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. , 2013, Sleep medicine.

[29]  W. Poewe,et al.  Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group , 2014, Movement disorders : official journal of the Movement Disorder Society.

[30]  G. Treglia,et al.  Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: A systematic review and a meta-analysis , 2011, Clinical Neurology and Neurosurgery.

[31]  M. Schocke,et al.  Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s Disease , 2010, Neurodegenerative Diseases.

[32]  D. Royall,et al.  Meta‐analysis of 123I‐MIBG cardiac scintigraphy for the diagnosis of Lewy body–related disorders , 2011, Movement disorders : official journal of the Movement Disorder Society.

[33]  N. Quinn,et al.  Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. , 2019, Brain : a journal of neurology.

[34]  Gerta Rücker,et al.  18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment , 2017, The Journal of Nuclear Medicine.

[35]  D. Gruber,et al.  Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker? , 2020, Movement disorders : official journal of the Movement Disorder Society.

[36]  R. Guy,et al.  Scanning the horizon: a systematic literature review of methodologies , 2019, BMJ Open.

[37]  S. Orimo,et al.  123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. , 2012, Parkinsonism & related disorders.

[38]  G. Ebersbach,et al.  Sonographic assessment of urinary retention in multiple system atrophy and idiopathic Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[39]  W. Poewe,et al.  Early distinction of Parkinson‐variant multiple system atrophy from Parkinson's disease , 2019, Movement disorders : official journal of the Movement Disorder Society.

[40]  M. Meade,et al.  A guide for the design and conduct of self-administered surveys of clinicians , 2008, Canadian Medical Association Journal.

[41]  K. Druschky,et al.  Differentiation of Parkinson’s disease and multiple system atrophy in early disease stages by means of I-123-MIBG–SPECT , 2000, Journal of the Neurological Sciences.

[42]  Jeremy D. Schmahmann,et al.  The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type , 2016, Cerebellum.

[43]  O. Rascol,et al.  MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy , 2018, Movement disorders : official journal of the Movement Disorder Society.

[44]  D. Margouleff,et al.  Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease , 1993, Annals of neurology.

[45]  P. Sandroni,et al.  Blood pressure recovery from Valsalva maneuver in patients with autonomic failure , 2005, Neurology.

[46]  D. Dickson,et al.  When DLB, PD, and PSP masquerade as MSA , 2015, Neurology.

[47]  P. Cortelli,et al.  Early stridor onset and stridor treatment predict survival in 136 patients with MSA , 2016, Neurology.

[48]  K. Xia,et al.  Prediction of orthostatic hypotension in multiple system atrophy and Parkinson disease , 2016, Scientific Reports.

[49]  Günther Deuschl,et al.  Red flags for multiple system atrophy , 2008, Movement disorders : official journal of the Movement Disorder Society.

[50]  S. Jeong,et al.  Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy , 2017, Neurourology and urodynamics.

[51]  Sonja W. Scholz,et al.  A critique of the second consensus criteria for multiple system atrophy , 2019, Movement disorders : official journal of the Movement Disorder Society.

[52]  R. Freeman,et al.  Natural history of pure autonomic failure: A United States prospective cohort , 2017, Annals of neurology.

[53]  W. Poewe,et al.  New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[54]  Han-Joon Kim,et al.  Should genetic testing for SCAs be included in the diagnostic workup for MSA? , 2014, Neurology.

[55]  W. Meissner,et al.  Laboratory‐Supported Multiple System Atrophy beyond Autonomic Function Testing and Imaging: A Systematic Review by the MoDiMSA Study Group , 2021, Movement disorders clinical practice.

[56]  M. Moscovich,et al.  Differential diagnosis of sporadic adult-onset ataxia: The role of REM sleep behavior disorder. , 2015, Parkinsonism & related disorders.

[57]  G. Wenning,et al.  Multiple-system atrophy. , 2015, The New England journal of medicine.

[58]  R. Freeman,et al.  Do we need to evaluate diastolic blood pressure in patients with suspected orthostatic hypotension? , 2017, Clinical Autonomic Research.

[59]  E. Benarroch,et al.  Pure autonomic failure , 2017, Neurology.

[60]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[61]  K. Kirchhof,et al.  Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study , 2003, International Journal of Impotence Research.

[62]  J. Jankovic,et al.  Natural History of Multiple System Atrophy in North America: A Prospective Cohort Study , 2015, The Lancet Neurology.

[63]  Günther Deuschl,et al.  The natural history of multiple system atrophy: a prospective European cohort study , 2013, The Lancet Neurology.

[64]  K. Iwanaga,et al.  Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[65]  Nocturnal decrease in vasopressin secretion into plasma in patients with multiple system atrophy , 1999, Journal of neurology, neurosurgery, and psychiatry.

[66]  Werner Poewe,et al.  Progression of falls in postmortem‐confirmed Parkinsonian disorders , 1999, Movement disorders : official journal of the Movement Disorder Society.

[67]  J. Trojanowski,et al.  Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy , 2007, Neuropathology and applied neurobiology.

[68]  G. Plazzi,et al.  Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies , 2020, Acta Neuropathologica.

[69]  W. Poewe,et al.  Urinary retention discriminates multiple system atrophy from Parkinson's disease , 2019, Movement disorders : official journal of the Movement Disorder Society.

[70]  W. Poewe,et al.  Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism , 2016, Neurology.

[71]  N. Quinn,et al.  Is sphincter electromyography a helpful investigation in the diagnosis of multiple system atrophy? A retrospective study with pathological diagnosis , 2005, Movement disorders : official journal of the Movement Disorder Society.

[72]  M. Skalej,et al.  Pontine MRI hyperintensities (“the cross sign”) are not pathognomonic for multiple system atrophy (MSA) , 2001, Movement disorders : official journal of the Movement Disorder Society.

[73]  Anna Barnes,et al.  FDG PET in the differential diagnosis of parkinsonian disorders , 2005, NeuroImage.

[74]  W. Oertel,et al.  Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study , 2015, Annals of neurology.

[75]  R. Freeman,et al.  Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies , 2018, Annals of neurology.

[76]  K. Seppi,et al.  Validation of the neurogenic orthostatic hypotension ratio with active standing. , 2020, Annals of Neurology.

[77]  Nick C Fox,et al.  Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy , 2012, Movement disorders : official journal of the Movement Disorder Society.